公司概覽
業務類別 Medical Instruments & Supplies
業務概覽 Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improvepatient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
公司地址 Friedrich-Ebert-Anlage 35-37, Frankfurt am Main, HE, DEU, 60327
電話號碼 +49 69870039170
傳真號碼 --
公司網頁 https://www.anbio.com
員工數量 27
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Michael Lau Chief Executive Officer -- 07/04/2026
Ms. Suki Song Chief Financial Officer -- 07/04/2026
Mr. Chris Tian Chief Business Officer -- 07/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Michael W. Zhang Independent Director 07/04/2026
Mr. Cany Xu Director 07/04/2026
Ms. Nancy Hartzler Independent Director 07/04/2026
Mr. David Hsu Independent Director 07/04/2026
 
所屬ETF (更新日期: 07/11/2026 02:55)
代號 名稱 佔比% ▼ 持有日期
GWXState Street® SPDR® S&P® Intl Sm Cp ETF0.06%30/10/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.